Literature DB >> 9312112

Tyrosine docking sites of the rat prolactin receptor required for association and activation of stat5.

A Pezet1, F Ferrag, P A Kelly, M Edery.   

Abstract

Prolactin (PRL) interacts with a single chain prolactin-specific receptor of the cytokine receptor superfamily. PRL triggers activation of Jak2 kinase which phosphorylates the PRL receptor itself and the mammary gland factor, Stat5, a member of the family of signal transducers and activators of transcription (Stat). Selection of the particular substrate (Stat 5), that is characterized by transcriptional responses to PRL, has been shown to be determined by specific tyrosine-based motifs common to many cytokine receptors. PRL-induced activation of Stat5 was abolished in 293 fibroblasts expressing PRL receptor mutants lacking all intracellular tyrosines. We have identified tyrosine phosphorylation sites of the PRL receptor (residues 580, 479, and 473) necessary for maximal Stat5 activation and subsequent Stat5-dependent gene transcription. Moreover, we have shown that none of the tyrosine residues of the PRL receptor are implicated in activation of Jak2. This study demonstrates that only specific tyrosines in the PRL receptor are phosphorylated and are in fact utilized differentially for Stat5-mediated transcriptional signaling.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9312112     DOI: 10.1074/jbc.272.40.25043

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Alternative TEL-JAK2 fusions associated with T-cell acute lymphoblastic leukemia and atypical chronic myelogenous leukemia dissected in zebrafish.

Authors:  Sara M N Onnebo; Parisa Rasighaemi; Janani Kumar; Clifford Liongue; Alister C Ward
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

Review 2.  New insights in prolactin: pathological implications.

Authors:  Valérie Bernard; Jacques Young; Philippe Chanson; Nadine Binart
Journal:  Nat Rev Endocrinol       Date:  2015-03-17       Impact factor: 43.330

3.  Two independent histidines, one in human prolactin and one in its receptor, are critical for pH-dependent receptor recognition and activation.

Authors:  Mandar V Kulkarni; M Cristina Tettamanzi; James W Murphy; Camille Keeler; David G Myszka; Naomi E Chayen; Elias J Lolis; Michael E Hodsdon
Journal:  J Biol Chem       Date:  2010-09-30       Impact factor: 5.157

Review 4.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

5.  Histone H1 and Chromosomal Protein HMGN2 Regulate Prolactin-induced STAT5 Transcription Factor Recruitment and Function in Breast Cancer Cells.

Authors:  Suzanne M Schauwecker; J Julie Kim; Jonathan D Licht; Charles V Clevenger
Journal:  J Biol Chem       Date:  2016-12-29       Impact factor: 5.157

Review 6.  Regulation of prolactin receptor levels and activity in breast cancer.

Authors:  G Swaminathan; B Varghese; S Y Fuchs
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-01-19       Impact factor: 2.673

Review 7.  Molecular mechanisms of prolactin and its receptor.

Authors:  Charles L Brooks
Journal:  Endocr Rev       Date:  2012-05-10       Impact factor: 19.871

8.  Expression of long-form prolactin receptor is associated with lower disease-free and overall survival in node-negative breast cancer patients.

Authors:  Doonyapat Sa-Nguanraksa; Kwanlada Mitpakdi; Norasate Samarnthai; Thanawat Thumrongtaradol; Pornchai O-Charoenrat
Journal:  Gland Surg       Date:  2021-01

9.  The human intermediate prolactin receptor is a mammary proto-oncogene.

Authors:  Jacqueline M Grible; Patricija Zot; Amy L Olex; Shannon E Hedrick; J Chuck Harrell; Alicia E Woock; Michael O Idowu; Charles V Clevenger
Journal:  NPJ Breast Cancer       Date:  2021-03-26

Review 10.  STAT5-Interacting Proteins: A Synopsis of Proteins that Regulate STAT5 Activity.

Authors:  Ashley A Able; Jasmine A Burrell; Jacqueline M Stephens
Journal:  Biology (Basel)       Date:  2017-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.